• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

    94.17 -0.82 (-0.86%)
    Streaming Delayed Price Updated: 11:04 AM EDT, Sep 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 45,550
    Open 94.95
    Bid (Size) 94.17 (1)
    Ask (Size) 94.81 (2)
    Prev. Close 94.99
    Today's Range 94.16 - 95.12
    52wk Range 52.50 - 99.50
    Shares Outstanding 24,422,240
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    6 Analysts Have This To Say About ANI Pharmaceuticals
     
    Via Benzinga
    3 Small-Cap Stocks We Approach with Caution
    Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
    Via StockStory

    Performance

    YTD
    +69.9%
    +69.9%
    1 Month
    +4.3%
    +4.3%
    3 Month
    +42.9%
    +42.9%
    6 Month
    +40.2%
    +40.2%
    1 Year
    +60.9%
    +60.9%

    More News

    Read More
    ANI Pharmaceuticals Inc (NASDAQ:ANIP) Presents a High Growth Momentum and Technical Breakout Opportunity
    Via Chartmill
    3 Unpopular Stocks with Questionable Fundamentals
    Via StockStory
    4 Analysts Have This To Say About ANI Pharmaceuticals
    Via Benzinga
    ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors
    Via Stocktwits
    Topics Government
    Earnings Preview For ANI Pharmaceuticals
    Via Benzinga
    3 Russell 2000 Stocks with Questionable Fundamentals
    Via StockStory
    A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Generic Pharmaceuticals Stocks Q2 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Best of the Bunch
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    ANI Pharmaceuticals Inc (NASDAQ:ANIP) Shows Strong Momentum and Growth, Fitting Minervini's Trend-Following Criteria
    Via Chartmill
    1 Mooning Stock for Long-Term Investors and 2 That Underwhelm
    Via StockStory
    Topics Emissions
    Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    3 Healthcare Stocks We’re Skeptical Of
    Via StockStory
    Topics Stocks
    Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Earnings Economy
    ANIP Q2 Deep Dive: Rare Disease Expansion Fuels Outperformance, Generics Maintain Solid Trajectory
    Via StockStory
    Why ANI Pharmaceuticals (ANIP) Stock Is Up Today
    Via StockStory
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    ANI Pharmaceuticals Inc (NASDAQ:ANIP) Reports Record Q2 2025 Earnings, Beats Estimates and Raises Full-Year Guidance
    Via Chartmill
    Topics Earnings
    ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2: Strong Sales, Stock Soars
    Via StockStory
    Earnings Scheduled For August 8, 2025
    Via Benzinga
    ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect
    Via StockStory
    Topics Government World Trade
    Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
    From CG Oncology Inc.
    Via GlobeNewswire
    Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    Q1 Earnings Highs And Lows: Viatris (NASDAQ:VTRS) Vs The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property

    Frequently Asked Questions

    Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
    ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
    What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
    The current price of ANI Pharmaceuticals, Inc. - Common Stock is 94.17
    When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 09/25/25 11:04 AM ET
    What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 2.30B
    How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
    ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.